CRESSKILL, N.J. and JERUSALEM, Might 03, 2021 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Firm”), a world chief in superior noninvasive neurostimulation therapies for psychological well being problems, right now introduced that the Firm will ring the NASDAQ closing bell on Wednesday, Might 5, 2021, to spotlight Might as Psychological Well being Consciousness Month.
“We’re thrilled to have the chance to lift consciousness of Might as Psychological Well being Consciousness Month by ringing the NASDAQ closing bell,” acknowledged Christopher von Jako, Ph.D., President and Chief Government Officer of BrainsWay. “The continued world COVID-19 pandemic has led to a major rise in a large number of psychological well being situations, and it’s essential that we spotlight the varied sources accessible to these in want. BrainsWay is devoted to creating and offering superior options for mind problems utilizing our revolutionary expertise, Deep Transcranial Magnetic Stimulation, or Deep TMS, which has been utilized to deal with over 100,000 sufferers for melancholy and obsessive-compulsive dysfunction. I wish to thank NASDAQ for his or her assist in serving to us drive recognition of the psychological well being disaster and the dedication of healthcare suppliers by permitting us to ring the closing bell on behalf of our devoted staff who attempt every day to boldly advance neuroscience to enhance well being and rework lives.”
The ceremony will start at roughly 3:45 p.m. ET on Wednesday, Might 5, 2021, and may be considered reside at https://www.nasdaq.com/marketsite/bell-ringing-ceremony.
BrainsWay is a world chief in superior noninvasive neurostimulation therapies for psychological well being problems. The Firm is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform expertise to enhance well being and rework lives. BrainsWay is the primary and solely TMS firm to acquire three FDA-cleared indications backed by pivotal research demonstrating clinically confirmed efficacy. Present indications embody main depressive dysfunction, obsessive-compulsive dysfunction, and smoking dependancy. The Firm is devoted to main by superior science and constructing on its unparalleled physique of medical proof. Further medical trials of Deep TMS in varied psychiatric, neurological, and dependancy problems are underway. Based in 2003, with workplaces in Cresskill, NJ and Jerusalem, Israel, BrainsWay is dedicated to growing world consciousness and broad entry to Deep TMS. For the newest information and details about BrainsWay, please go to www.brainsway.com.
Ahead Wanting Statements
This press launch incorporates “forward-looking statements” inside the that means of the Personal Securities Litigation Reform Act of 1995. Such statements could also be preceded by the phrases “intends,” “could,” “will,” “plans,” “expects,” “anticipates,” “tasks,” “predicts,” “estimates,” “goals,” “believes,” “hopes,” “potential” or comparable phrases. These forward-looking statements and their implications are based mostly on the present expectations of the administration of the Firm solely and are topic to a variety of components and uncertainties that would trigger precise outcomes to vary materially from these described within the forward-looking statements. The next components, amongst others, may trigger precise outcomes to vary materially from these described within the forward-looking statements: inadequacy of monetary sources to fulfill future capital necessities; adjustments in expertise and market necessities; delays or obstacles in launching and/or efficiently finishing deliberate research and medical trials; failure to acquire approvals by regulatory businesses on the Firm’s anticipated timeframe, or in any respect; lack of ability to retain or appeal to key workers whose information is crucial to the event of Deep TMS merchandise; unexpected difficulties with Deep TMS merchandise and processes, and/or lack of ability to develop essential enhancements; surprising prices associated to Deep TMS merchandise; failure to acquire and keep satisfactory safety of the Firm’s mental property, together with mental property licensed to the Firm; the potential for product legal responsibility; adjustments in laws and relevant guidelines and laws; unfavorable market notion and acceptance of Deep TMS expertise; insufficient or delays in reimbursement from third-party payers, together with insurance coverage firms and Medicare; lack of ability to commercialize Deep TMS, together with internationally, by the Firm or by third-party distributors; product improvement by rivals; lack of ability to well timed develop and introduce new applied sciences, merchandise and functions, and the impact of the worldwide COVID-19 well being pandemic on our enterprise and continued uncertainty and market impression relating thereto.
Any forward-looking assertion on this press launch speaks solely as of the date of this press launch. The Firm undertakes no obligation to publicly replace or evaluation any forward- trying assertion, whether or not on account of new info, future developments or in any other case, besides as could also be required by any relevant securities legal guidelines. Extra detailed details about the dangers and uncertainties affecting the Firm is contained beneath the heading “Threat Elements” within the Firm’s filings with the U.S. Securities and Change Fee, together with the Firm’s Annual Report on Kind 20-F. Buyers and safety holders are urged to learn these paperwork freed from cost on the SEC’s web page at http://www.sec.gov.
SVP and Normal Supervisor